COR - Cencora, Inc.

371.44
-1.210   -0.326%

Share volume: 1,190,357
Last Updated: 03-03-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries: -0.09%

PREVIOUS CLOSE
CHG
CHG%
$372.65
-1.21
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
55%
Profitability 43%
Dept financing 37%
Liquidity 46%
Performance 74%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.19%
1 Month
12.57%
3 Months
10.01%
6 Months
26.90%
1 Year
46.65%
2 Year
48.19%
Key data
Stock price
$371.44
P/E Ratio 
40.32
DAY RANGE
$362.64 - $373.77
EPS 
$8.38
52 WEEK RANGE
$248.59 - $377.54
52 WEEK CHANGE
$47.67
MARKET CAP 
65.521 B
YIELD 
0.67%
SHARES OUTSTANDING 
194.531 M
DIVIDEND
$0.60
EX-DIVIDEND DATE
02-13-2026
NEXT EARNINGS DATE
07-30-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$1,023,978
AVERAGE 30 VOLUME 
$1,310,556
Company detail
CEO: Steven H. Collis
Region: US
Website: www.cencora.com
Employees: 42,000
IPO year: 1995
Issue type:
Market: NYSE
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade

Cencora, Inc. sources and distributes pharmaceutical products. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Recent news